Long-Term Study Of CP-690,550 In Subjects With Ulcerative Colitis (OCTAVE)

Long-Term Study Of CP-690,550 In Subjects With Ulcerative Colitis (OCTAVE). A Multi-Center, Open-Label Study of CP-690,550 in Participants With Moderate to Severe Ulcerative Colitis

Category & Conditions:
Immune System Diseases and Conditions
Medicine:
XELJANZ®(TOFACITINIB)
ClinicalTrials.gov Identifier (NCT):
Protocol ID:
A3921139
Open Plain Language Summary Result:Click here